This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wewer, U. M. Articles by Mercurio, A. M. Search for Related Content PubMed PubMed Citation Articles by Wewer, U. M. Articles by Mercurio, A. M.

American Journal of Pathology, Vol 151, 1191-1198, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

The integrin alpha 6 beta 1 promotes the survival of metastatic human breast carcinoma cells in mice

UM Wewer, LM Shaw, R Albrechtsen and AM Mercurio
Institute of Molecular Pathology, University of Copenhagen, Denmark.

The role of the integrin alpha 6 beta 1 in breast carcinoma progression was studied by targeted elimination of this integrin in MDA-MB-435 cells, a human breast carcinoma cell line that is highly metastatic in athymic mice. The strategy used is based on the finding that expression of a cytoplasmic domain deletion mutant of the beta 4-integrin subunit (beta 4-delta CYT) in MDA-MB-435 cells eliminates formation of the alpha 6 beta 1 heterodimer. MDA-MB-435 cells that lacked alpha 6 beta 1 expression (beta 4-delta CYT transfectants) formed tumors in athymic mice that were suppressed in their growth and that exhibited a significant increase in apoptosis in comparison to the control tumors. Unlike the control MDA-MB-435 cells, the beta 4-delta CYT transfectants were unable to establish metastatic foci in the lungs. Also, the control transfectants grew substantially better than the beta 4-delta CYT transfectants in the liver after intrahepatic injection because of extensive apoptosis in the beta 4-delta CYT transfectants. These data suggest that a major function of the alpha 6 beta 1 integrin in breast carcinoma is to facilitate tumorigenesis and promote tumor cell survival in distant organs.

This article has been cited by other articles:

				J. Chia, N. Kusuma, R. Anderson, B. Parker, B. Bidwell, L. Zamurs, E. Nice, and N. Pouliot Evidence for a Role of Tumor-Derived Laminin-511 in the Metastatic Progression of Breast Cancer Am. J. Pathol., June 1, 2007; 170(6): 2135 - 2148. [Abstract] [Full Text] [PDF]

				J. Chung, S. Yoon, K. Datta, R. E. Bachelder, and A. M. Mercurio Hypoxia-Induced Vascular Endothelial Growth Factor Transcription and Protection from Apoptosis Are Dependent on {alpha}6{beta}1 Integrin in Breast Carcinoma Cells Cancer Res., July 15, 2004; 64(14): 4711 - 4716. [Abstract] [Full Text] [PDF]

				H. Wang, W. Fu, J. H. Im, Z. Zhou, S. A. Santoro, V. Iyer, C. M. DiPersio, Q.-C. Yu, V. Quaranta, A. Al-Mehdi, et al. Tumor cell {alpha}3{beta}1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis J. Cell Biol., March 15, 2004; 164(6): 935 - 941. [Abstract] [Full Text] [PDF]

				J. H. Wang, B. J. Manning, Q. D. Wu, S. Blankson, D. Bouchier-Hayes, and H. P. Redmond Endotoxin/Lipopolysaccharide Activates NF-{kappa}B and Enhances Tumor Cell Adhesion and Invasion Through a {beta}1 Integrin-Dependent Mechanism J. Immunol., January 15, 2003; 170(2): 795 - 804. [Abstract] [Full Text] [PDF]

				I. B. DeRoock, M. E. Pennington, T. C. Sroka, K. S. Lam, G. T. Bowden, E. L. Bair, and A. E. Cress Synthetic Peptides Inhibit Adhesion of Human Tumor Cells to Extracellular Matrix Proteins Cancer Res., April 1, 2001; 61(8): 3308 - 3313. [Abstract] [Full Text]

				C. W. Wong, A. Lee, L. Shientag, J. Yu, Y. Dong, G. Kao, A. B. Al-Mehdi, E. J. Bernhard, and R. J. Muschel Apoptosis: An Early Event in Metastatic Inefficiency Cancer Res., January 1, 2001; 61(1): 333 - 338. [Abstract] [Full Text]

				H. Qiao, R. Saulnier, A. Patryzkat, N. Rahimi, L. Raptis, J. Rossiter, E. Tremblay, and B. Elliott Cooperative Effect of Hepatocyte Growth Factor and Fibronectin in Anchorage-independent Survival of Mammary Carcinoma Cells: Requirement for Phosphatidylinositol 3-Kinase Activity Cell Growth Differ., February 1, 2000; 11(2): 123 - 133. [Abstract] [Full Text]

				R. E. Bachelder, M. J. Ribick, A. Marchetti, R. Falcioni, S. Soddu, K. R. Davis, and A. M. Mercurio p53 Inhibits {alpha}6{beta}4 Integrin Survival Signaling by Promoting the Caspase 3-dependent Cleavage of AKT/PKB J. Cell Biol., November 29, 1999; 147(5): 1063 - 1072. [Abstract] [Full Text] [PDF]

				G. J. Mizejewski Role of Integrins in Cancer: Survey of Expression Patterns Experimental Biology and Medicine, November 1, 1999; 222(2): 124 - 138. [Abstract] [Full Text]

				R. E. Bachelder, A. Marchetti, R. Falcioni, S. Soddu, and A. M. Mercurio Activation of p53 Function in Carcinoma Cells by the alpha 6beta 4 Integrin J. Biol. Chem., July 16, 1999; 274(29): 20733 - 20737. [Abstract] [Full Text] [PDF]

				N. Farrelly, Y.-J. Lee, J. Oliver, C. Dive, and C. H. Streuli Extracellular Matrix Regulates Apoptosis in Mammary Epithelium through a Control on Insulin Signaling J. Cell Biol., March 22, 1999; 144(6): 1337 - 1348. [Abstract] [Full Text] [PDF]

				M. Fornaro, M. Manzotti, G. Tallini, A. E. Slear, S. Bosari, E. Ruoslahti, and L. R. Languino ß1C Integrin in Epithelial Cells Correlates with a Nonproliferative Phenotype : Forced Expression of ß1C Inhibits ProstateEpithelial Cell Proliferation Am. J. Pathol., October 1, 1998; 153(4): 1079 - 1087. [Abstract] [Full Text] [PDF]